89.25 -0.05 (-0.06%)

43.51% Fall from 52W High

17,737 NSE+BSE Volume

NSE 21 Mar, 2025 3:31 PM (IST)



Board Meetings - Bal Pharma Ltd.

The latest board meeting for Bal Pharma Ltd. took place on 13 Feb 2025, for the purpose of Quarterly Results & Fund Raising

Ex-date Purpose Notes
13 Feb 2025 Quarterly Results & Fund Raising -
14 Nov 2024 Quarterly Results -
12 Aug 2024 Quarterly Results, ESOP & A.G.M. -
28 May 2024 Audited Results & Final Dividend -
12 Feb 2024 Quarterly Results -
08 Nov 2023 Quarterly Results & ESOP -
11 Aug 2023 Quarterly Results & A.G.M. -
29 May 2023 Audited Results & Final Dividend -
06 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results & ESOP Inter alia, To convene Extra Ordinary General Meeting ( EGM ) for merger of Golden Drugs Pvt Ltd. a wholly owned subsidiary of the Company.
11 Aug 2022 Quarterly Results -
30 May 2022 Audited Results & Final Dividend -
13 Apr 2022 Preferential issue of shares -
09 Mar 2022 Scheme of Amalgamation Inter alia consider approval of scheme of amalgamation between Bal Pharma Ltd and its wholly owned subsidiary i.e Golden Drugs Private Ltd.
10 Feb 2022 Quarterly Results -
11 Nov 2021 Quarterly Results -
10 Aug 2021 Quarterly Results -
29 Jun 2021 Audited Results & Final Dividend -
17 Mar 2021 Preferential Issue of shares Inter alia, to consider and approve allotment of equity shares to the beneficiaries who have exercised the conversion option on the warrants allotted to them on preferential basis.
11 Feb 2021 Quarterly Results & Others -
11 Nov 2020 Quarterly Results -
28 Oct 2020 To consider issue of Warrants To consider allotment of 14,00,000 warrants to Mr.Shailesh Siroya, promoter of the Company on preferential basis.
08 Sep 2020 Quarterly Results -
29 Jul 2020 Audited Results & A.G.M. -
29 Jun 2020 Audited Results -
12 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
13 Aug 2019 Quarterly Results (Revised)
08 Aug 2019 Quarterly Results -
30 May 2019 Audited Results & Final Dividend (Revised)
29 May 2019 Audited Results & Final Dividend -
13 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
10 Aug 2018 Quarterly Results -
29 May 2018 Audited Results & Dividend -
14 Feb 2018 Quarterly Results -
11 Dec 2017 Quarterly Results -
11 Sep 2017 Quarterly Results -
10 Aug 2017 Others To approve the 30th Annual General Meeting Notice (AGM), Directors Report and Corporate Governance reports of the Company, for the financial year ended 31.03.2017.
30 May 2017 Audited Results & Dividend -
07 Feb 2017 Quarterly Results -
14 Nov 2016 Quarterly Results -
10 Aug 2016 Quarterly Results To consider certain key business propositions.
25 May 2016 Audited Results & Dividend -
13 Apr 2016 Allotment of Equity Shares -
10 Feb 2016 Quarterly Results -
09 Nov 2015 Quarterly Results -
13 Aug 2015 Quarterly Results Appointed Mr. Sanjay Kumar Agarwal as Company Secretary and Compliance officer of the Company.
29 May 2015 Audited Results & Dividend -
27 Mar 2015 Others Appointed Ms.Sarika Bhandari as additional Director on the Board of the Company.
12 Feb 2015 Quarterly Results -
08 Nov 2014 Quarterly Results -
20 Oct 2014 Others To consider issue and allotment of warrants to the investors on preferential basis.
11 Aug 2014 Quarterly Results & Others Preferential Issue of shares
28 May 2014 Audited Results & Dividend -
12 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
12 Aug 2013 Quarterly Results -
27 May 2013 Audited Results & Dividend -
12 Feb 2013 Quarterly Results -
09 Nov 2012 Quarterly Results -
10 Aug 2012 Audited & Quarterly Results 1. Propose issue and allotment of warrants on preferential basis to the promoters and to strategic investors. 2. Approve the audited accounts of the Company for the F.Y. ended March 31, 2012.
10 May 2012 Quarterly Results -
03 Feb 2012 Quarterly Results -
08 Nov 2011 Quarterly Results -
10 Aug 2011 Audited & Quarterly Results -
15 May 2011 Quarterly Results (Revised)
31 Jan 2011 Quarterly Results -
13 Nov 2010 Quarterly Results -
06 Aug 2010 Audited & Quarterly Results -
14 May 2010 Quarterly Results -
27 Jan 2010 Quarterly Results -
31 Oct 2009 Quarterly Results -
27 Jul 2009 Quarterly Results -
29 Jun 2009 Audited Results & Dividend -
28 May 2009 Scheme of Amalgamation To consider & approve the draft Scheme of Amalgamation of Basav Chem Ltd. (100% subsidiary Company) , with the Company in terms of Sections 391 to 394 of the Companies Act, 1956.
30 Jan 2009 Quarterly Results -
27 Oct 2008 Quarterly Results & Others To allot 37,000 equity shares of face value @ Rs 10/- each, allotted at Rs 15.75/- per equity share to the eligible employees of the Company under ESOP Scheme, 2006.
30 Jul 2008 Quarterly Results -
23 Jun 2008 Audited Results & Dividend -
16 Apr 2008 Others Inter alia, to take on record the sales performance of the Company, up to March 31, 2008.
24 Jan 2008 Quarterly Results -
30 Oct 2007 Quarterly Results -
30 Jul 2007 Quarterly Results -
30 Jun 2007 Audited Results -
31 Jan 2007 Quarterly Results -
27 Oct 2006 Quarterly Results -
31 Jul 2006 Quarterly Results -
30 Jun 2006 Accounts -
30 Apr 2006 Quarterly Results -
30 Jan 2006 Quarterly Results -
29 Oct 2005 Quarterly Results -
30 Jul 2005 Quarterly Results -
30 Jun 2005 Accounts & Dividend -
31 May 2005 Others To review of the response of the shareholders with regard to Right Issue
31 Jan 2005 Quarterly Results -
26 Dec 2004 Right Issue of Equity Shares & To obtain share holders approval by postal ballot to amend object clause of the MOA.
31 Oct 2004 Quarterly Results -
07 Oct 2004 Preferential Issue of shares 1) Allotment of 10,30,000 shares on preferential basis and 2) Redemption of preference shares.
31 Jul 2004 Others Approved allotment of Equity shares on Preferential basis